ALDX
Price
$5.49
Change
-$0.00 (-0.00%)
Updated
Nov 11 closing price
114 days until earnings call
OBIO
Price
$6.13
Change
-$0.00 (-0.00%)
Updated
Nov 11 closing price
Ad is loading...

ALDX vs OBIO

Header iconALDX vs OBIO Comparison
Open Charts ALDX vs OBIOBanner chart's image
Aldeyra Therapeutics
Price$5.49
Change-$0.00 (-0.00%)
Volume$350.65K
CapitalizationN/A
Orchestra BioMed Holdings
Price$6.13
Change-$0.00 (-0.00%)
Volume$41.12K
CapitalizationN/A
ALDX vs OBIO Comparison Chart
Loading...
ALDX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
OBIO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ALDX vs. OBIO commentary
Nov 13, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALDX is a Sell and OBIO is a Hold.

COMPARISON
Comparison
Nov 13, 2024
Stock price -- (ALDX: $5.49 vs. OBIO: $6.01)
Brand notoriety: ALDX and OBIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALDX: 85% vs. OBIO: 68%
Market capitalization -- ALDX: $282.85M vs. OBIO: $214.09M
ALDX [@Biotechnology] is valued at $282.85M. OBIO’s [@Biotechnology] market capitalization is $214.09M. The market cap for tickers in the [@Biotechnology] industry ranges from $492.19B to $0. The average market capitalization across the [@Biotechnology] industry is $2.81B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALDX’s FA Score shows that 0 FA rating(s) are green whileOBIO’s FA Score has 0 green FA rating(s).

  • ALDX’s FA Score: 0 green, 5 red.
  • OBIO’s FA Score: 0 green, 5 red.
According to our system of comparison, ALDX is a better buy in the long-term than OBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALDX’s TA Score shows that 3 TA indicator(s) are bullish while OBIO’s TA Score has 6 bullish TA indicator(s).

  • ALDX’s TA Score: 3 bullish, 6 bearish.
  • OBIO’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, OBIO is a better buy in the short-term than ALDX.

Price Growth

ALDX (@Biotechnology) experienced а +5.98% price change this week, while OBIO (@Biotechnology) price change was +10.07% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.24%. For the same industry, the average monthly price growth was +11.71%, and the average quarterly price growth was +7.66%.

Reported Earning Dates

ALDX is expected to report earnings on Mar 06, 2025.

OBIO is expected to report earnings on Jan 25, 2023.

Industries' Descriptions

@Biotechnology (+1.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALDX($283M) has a higher market cap than OBIO($214M). ALDX YTD gains are higher at: 56.410 vs. OBIO (-34.173). ALDX has higher annual earnings (EBITDA): -35.59M vs. OBIO (-58M). ALDX has more cash in the bank: 120M vs. OBIO (65.2M). OBIO has less debt than ALDX: OBIO (1.45M) vs ALDX (15.6M). OBIO has higher revenues than ALDX: OBIO (2.08M) vs ALDX (0).
ALDXOBIOALDX / OBIO
Capitalization283M214M132%
EBITDA-35.59M-58M61%
Gain YTD56.410-34.173-165%
P/E RatioN/AN/A-
Revenue02.08M-
Total Cash120M65.2M184%
Total Debt15.6M1.45M1,074%
FUNDAMENTALS RATINGS
ALDX: Fundamental Ratings
ALDX
OUTLOOK RATING
1..100
71
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
36

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALDXOBIO
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
67%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
48%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
40%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
44%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
45%
Advances
ODDS (%)
Bullish Trend 7 days ago
82%
Bullish Trend 7 days ago
55%
Declines
ODDS (%)
Bearish Trend 13 days ago
80%
Bearish Trend 13 days ago
69%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
54%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
59%
View a ticker or compare two or three
Ad is loading...
ALDX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
OBIO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VZGRX58.721.29
+2.25%
Virtus Zevenbergen Innovative Gr Stk R6
BAUAX35.070.62
+1.80%
Brown Advisory Small-Cap Fdmtl Val Adv
VGIIX89.790.56
+0.63%
JPMorgan US Value I
HBFBX12.14N/A
N/A
Hennessy Balanced Investor
TNVIX18.79N/A
N/A
1290 GAMCO Small/Mid Cap Value I

ALDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALDX has been loosely correlated with CANF. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ALDX jumps, then CANF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALDX
1D Price
Change %
ALDX100%
-0.54%
CANF - ALDX
46%
Loosely correlated
-0.47%
FOLD - ALDX
46%
Loosely correlated
-2.73%
QSI - ALDX
44%
Loosely correlated
+6.39%
ACLX - ALDX
42%
Loosely correlated
+3.37%
CHRS - ALDX
42%
Loosely correlated
-3.79%
More

OBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, OBIO has been loosely correlated with INSM. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if OBIO jumps, then INSM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OBIO
1D Price
Change %
OBIO100%
-2.75%
INSM - OBIO
36%
Loosely correlated
-2.31%
AURA - OBIO
35%
Loosely correlated
+2.39%
CALC - OBIO
33%
Poorly correlated
+1.15%
ALDX - OBIO
32%
Poorly correlated
-0.54%
OMER - OBIO
32%
Poorly correlated
-2.49%
More